In teofyllinespegel fan 5–15 mg/L kin in gaadlik behannelingsdoel wêze, mar gjin inkelde útslach garandearret feiligens. It momint fan dosearring, de formulearring, symptomen en resinte feroarings yn smoken of medisinen bepale wat jo getal betsjut.
Wichtichste punten
- Behannelingsdoel: In protte kliïnten brûke 5–15 mg/L, hoewol’t guon laboratoaria 10–20 mg/L oanjaan; it doel fan jo foarskriuwer giet foar.
- Heech resultaat: In teofyllinespegel boppe 20 mg/L fergruttet de soarch oer toksisiteit en fereasket prompt klinysk advys.
- Symptomen geane foar it referinsjeberik: Oanhâldend braken, in bonkjend of ûnregelmjittich hertslach, betizing of in kramp kinne op toksisiteit wize, ek ûnder 20 mg/L.
- Ienheden: 1 mg/L is lyk oan 1 µg/mL; fermannichfâldigje mg/L mei likernôch 5.55 om om te rekkenjen nei µmol/L.
- Monsterôfname op it juste momint: Preparaten mei direkte frijlitting en preparaten mei modifisearre frijlitting hawwe ferskillende pyktiden; in dalwearde kin net samar ferlike wurde mei in pykwurde.
- Ophâlde mei smoken: Ophâlde mei smoken kin de klaring fan theofylline binnen sawat 1 wike flink ferminderje, sels as nikotineferfanging brûkt wurdt.
- Koarts: In oanhâldende temperatuer om de 39°C hinne foar op syn minst 24 oeren kin de klaring fertrage en it nivo ferheegje by in ûnferoare doasis.
- Ynteraksjes: Ciprofloxacin, fluvoxamine, cimetidine en guon makrolide-antibiotika kinne de konsintraasjes fan theofylline ferheegje.
- Aksje by need: Sykje medyske help by in epileptyske oanfal, ynstoarten, slimme betizing of in oanhâldend rappe of ûnregelmjittige hertslach; wachtsje net op in oare mjitting.
Hokker teofyllinespegel wurdt as feilich beskôge?
A theofyllinenivo fan 5–15 mg/L is in faak brûkt behanneldoel, wylst guon laboratoaria 10–20 mg/L. rapportearje. Toksisiteit wurdt wierskynliker boppe 20 mg/L, mar symptomen kinne binnen it oanjûne berik foarkomme; it doel fan de klinikus en de timing fan de ôfname binne wichtiger as allinnich de laboratoariumflagge.
Theofylline hat in smelle terapeutyske marzje, wat betsjut dat it ferskil tusken in brûkbere konsintraasje en in skealike konsintraasje relatyf lyts is. In resultaat fan 14 mg/L kin passe by it behannelplan fan de iene persoan, mar ûnnedich heech wêze foar in oar dy't mei 7 mg/L genôch symptoomkontrôle hat, benammen as der neidielige effekten of fermindere klaring binne.
Hegere konsintraasjes betsjutte net automatysk in bettere behanneling fan de luchtwegen. Barnes syn resinsje yn it American Journal of Respiratory and Critical Care Medicine beskriuwt sawol bronchodilataasje-effekten as foarstelde anty-inflammatoire meganismen by legere konsintraasjes, mar dit binne gjin útwikselbere behanneldoelen (Barnes, 2013). In foarsteld biologysk effekt by 1–5 mg/L rjochtfeardiget net it ferheegjen of ferleegjen fan in foarskreaune doasis sûnder it werklike klinyske foardiel te beoardieljen.
Kantesti is in AI-bloedtestanalysator dy't helpt út te lizzen wêrom't in theofyllineresultaat fan 12 mg/L in dosearhistoarje nedich hat, net allinnich in griene laboratoariumflagge. Wy jouwe edukative ynterpretaasje ynstee fan besluten oer foarskriuwen; ús organisaasje en doel lizze dat ûnderskied út. Nim it resultaat, de krekte medisinenamme, it tiidstip fan de lêste doasis en resinte symptomen mei nei it foarskriuwende team.
Hoe kinne jo it terapeutyske berik en de ienheden fan teofylline lêze
De terapeutysk berik fan theofylline beskriuwt in bedoelde medisynblootstelling, net in normale wearde foar in persoan dy't gjin behanneling krijt. 1 mg/L is lyk oan 1 µg/mL, en in resultaat yn µmol/L is likernôch 5.55 kear sa grut as deselde konsintraasje útdrukt yn mg/L.
In konsintraasje fan 10 mg/L is likernôch 55.5 µmol/L, while 20 mg/L is approximately 111 µmol/L. Check the units before comparing reports from different countries, because a number such as 83 may represent approximately 15 mg/L rather than an extreme overdose. A therapeutic range also assumes a particular sampling approach, which may not be printed beside the result.
A laboratory upper limit of 20 mg/L is not an instruction to aim for 20 mg/L. NICE’s COPD guideline recommends plasma-level and interaction monitoring when theophylline is used, with particular caution in older people and during relevant antibiotic treatment (NICE, 2018). Similar distinctions between laboratory ranges and individualized targets appear in our guide to digoxin targets and timing.
Results between 15 and 20 mg/L deserve context rather than automatic reassurance or an automatic toxicity diagnosis. For a hypothetical person whose agreed target is 5–10 mg/L, a reading of 18 mg/L is above their treatment goal despite falling within a printed 10–20 mg/L interval. Ask whether the range applies to a peak, trough or other timed sample before interpreting the color coding.
| Nivo | Berik | Wat it betsjut |
|---|---|---|
| Common lower treatment target | 5–15 mg/L | Often suitable when clinical benefit is adequate; safety still depends on symptoms, timing and individual risk. |
| Upper part of some laboratory ranges | >15–20 mg/L | May exceed the clinician’s target; review adverse effects and whether the sample was correctly timed. |
| Above the usual upper boundary | >20–30 mg/L | Increased toxicity concern; obtain prompt clinical advice, with urgent assessment if symptoms are present. |
| Dúdlik ferhege | >30 mg/L | Urgent clinical assessment is needed, especially with chronic exposure; serious toxicity depends on symptoms and exposure pattern. |
Wannear moat in teofyllinemonster ôfnommen wurde?
A theophylline sample must be timed to the specific product and monitoring question. Immediate-release oral products often peak around 1–2 hours, whereas some modified-release monitoring protocols use samples 4–6 hours after dosing; these windows are not interchangeable.
A trough sample is collected just before the next scheduled dose, but theophylline monitoring is not always based on troughs. A low predose result may coexist with a substantially higher postdose peak, so increasing treatment solely because a trough is below a peak-based 10–20 mg/L range can be unsafe. The laboratory request should state what the prescriber intends to measure.
A result of 9 mg/L collected 2 hours after a dose cannot be compared directly with 9 mg/L collected 12 hours after a dose. Kantesti can help organize the reported concentration alongside supplied timing details, but missing dose times remain missing information. Our explanation of peak and trough sampling illustrates the principle, although gentamicin’s timing rules must not be transferred to theophylline.
Suspected toxicity requires immediate sampling rather than waiting for a scheduled peak or trough. If symptoms develop 3 hours after an extra dose, clinicians need that history and may arrange serial concentrations because absorption can continue. Write down actual times, not simply “morning” or “after tablets,” and do not delay urgent care to produce a more neatly timed result.
Wêrom’t de formulearring en de steady state de útslach feroarje
Immediate-release, twice-daily modified-release and once-daily theophylline products can produce different concentration patterns. A level is most interpretable after a stable regimen has reached steady state, commonly assessed after about 3 dagen, although slower clearance can require longer.
A three-day interval is a monitoring convention, not a guarantee that every person has stabilized. With a hypothetical half-life of 8 hours, five half-lives take about 40 hours; with a half-life of 24 hours, they take about 5 days. Fever, liver impairment and heart failure can extend that interval, so an early result may underestimate the eventual concentration on the same dose.
Changing a modified-release brand can change the shape of the concentration curve even when the daily milligram dose is unchanged. Food effects and peak timing differ between products, including some once-daily preparations whose peaks occur later than 4–6 hours. The broader lesson resembles formulation-specific drug monitoring, but each medicine needs its own product-specific instructions.
Modified-release tablets should not be crushed unless the product information explicitly permits the intended method of administration. For example, a prescribed 200 mg tablet may have a score line without being suitable for crushing, and destroying a release mechanism can increase early exposure. Keep the box or a photograph of its exact name available, especially after a pharmacy substitution, hospital discharge or change in dosing schedule.
By hokker symptomen fan teofyllinetoksisiteit is driuwende soarch nedich?
Theophylline toxicity symptoms include nausea, repeated vomiting, tremor, restlessness, insomnia and a rapid heartbeat. Seizures, collapse, severe confusion or a sustained rapid or irregular heartbeat require emergency care, even if a previous theophylline level was below 20 mg/L.
Persistent vomiting with a racing heartbeat is more concerning than either symptom considered alone in someone taking theophylline. Both can reflect excessive drug effect, while vomiting also disrupts fluid and electrolyte balance. A hypothetical pulse of 125 beats per minute accompanied by repeated vomiting should not be dismissed as anxiety simply because yesterday’s concentration was 16 mg/L.
Theophylline and inhaled beta-agonists can both cause tremor and palpitations, making symptom attribution difficult without assessment. Potassium, magnesium, an ECG and the current level may help distinguish medication effects from other causes; our gids foar testen fan palpitaasjes explains why a concentration alone is insufficient. A pulse above 100 beats per minute is not itself a toxicity diagnosis, but a new sustained change deserves attention.
If toxicity is suspected, do not take another theophylline dose while obtaining urgent medical advice. Seek emergency help immediately for a seizure, collapse or severe cardiac symptoms rather than waiting 1–2 hours for a routine service to respond. Do not induce vomiting or take activated charcoal at home; bring the medicine packaging and details of all doses, including any accidentally repeated tablets.
Kin toksisiteit foarkomme binnen it laboratoariumreferinsjeberik?
Theophylline toxicity can occur within a laboratory’s 10–20 mg/L range because susceptibility, sampling time and protein binding vary. A total concentration of 17 mg/L does not exclude an earlier higher peak or an unusually large proportion of active, unbound drug.
Routine theophylline assays usually measure total drug, including both protein-bound and unbound fractions. Approximately 40% is normally protein bound, but binding can decrease in circumstances such as cirrhosis, acidemia or late pregnancy. Our albumine- en proteïnegids helps explain the context, although albumin alone cannot reliably calculate an individual free theophylline concentration.
A free theophylline measurement may help when symptoms conflict with the total result. Product labeling describes an unbound therapeutic interval of approximately 6–12 mg/L, but this is not a routine target for every patient or a conversion formula. For a hypothetical total result of 15 mg/L with reduced binding, a clinician may request the free fraction instead of assuming that the laboratory’s total-drug interval establishes safety.
Kantesti is an AI blood test interpretation platform that explains why a symptomatic result of 17 mg/L deserves clinical review rather than automatic reassurance. Ús oanpak foar klinyske falidaasje describes the distinction between interpretation and a prescribing decision. People over 60 years, those with neurological disease and those with hypoxia may be more vulnerable, but no single age or albumin cutoff predicts all adverse effects.
Hoe’t ophâlde mei smoken in teofyllinespegel ferheegje kin
Stopping smoking can raise theophylline concentrations on an unchanged dose because tobacco smoke induces enzymes that clear the medicine. US product labeling reports an approximately 40% reduction in clearance after 1 week of abstinence, although the individual change varies.
Nicotine is not the main driver of the smoking–theophylline interaction. Combustion-related chemicals induce CYP1A2, so nicotine patches, gum or switching away from cigarettes do not reliably preserve the previous clearance rate. A cotinine result and nicotine exposure can document nicotine use, but it cannot establish whether theophylline-metabolizing enzyme induction remains unchanged after 7 smoke-free days.
A reduction in clearance can produce a larger concentration rise than the percentage initially suggests. In a deliberately simplified example, a stable concentration of 10 mg/L with clearance falling to 60% of its previous value would become approximately 16.7 mg/L if dose, absorption and other factors stayed constant. Actual theophylline kinetics can be nonlinear, so this calculation explains the risk rather than providing a dose-adjustment rule.
Smoking cessation should be supported, not discouraged because of theophylline monitoring. Tell the prescribing team when smoking stops, substantially decreases or restarts, and ask for an early reassessment plan rather than waiting for the next annual review. Kantesti can help place two dated results alongside a recorded smoking change, but clinicians must decide whether a dose reduction and repeat level within several days are appropriate.
Wêrom’t koarts en akute sykte de spegel ferheegje kinne
Sustained fever can slow theophylline clearance and raise the level without any dose increase. Product labeling highlights temperatures around 39°C lasting at least 24 hours as a meaningful warning pattern, but lower prolonged fevers and severe illness can also matter.
Fever-related accumulation can be mistaken for worsening respiratory illness. Nausea, poor sleep and tachycardia may be attributed to a chest illness even when theophylline contributes, particularly after 2–3 days of reduced clearance. Record the highest temperature, its duration, fluid intake and whether the regular tablets continued; these details can explain a rising result more usefully than a single inflammatory marker.
CRP and white-cell counts do not measure theophylline clearance. A person may need a drug level despite only modest changes in either test, while an elevated CRP does not prove that a concentration of 18 mg/L is toxic. Our explanation of WBC en CRP ferskil shows why illness severity cannot be reduced to one laboratory result.
Illness and its treatment can create two simultaneous reasons for accumulation. In a hypothetical case, a 39.2°C fever persisting for 30 hours plus newly prescribed ciprofloxacin warrants contact with the prescribing team even if the last stable level was 8 mg/L. Do not wait for the next scheduled monitoring appointment when new vomiting, tremor or palpitations accompany that combination.
Hokker medisinen kinne in hege teofyllinespegel feroarsaakje?
Ciprofloxacin, fluvoxamine, cimetidine and some macrolide antibiotics can raise theophylline levels by reducing clearance. The effect is drug-specific: 1 antibiotic cannot be assumed equivalent to another, and stopping an enzyme-inducing medicine can also cause accumulation.
Erythromycin and clarithromycin can interact with theophylline, while azithromycin generally has much less effect on its clearance. Ciprofloxacin is a recognized concern, but fluoroquinolones are not all identical in this respect. NICE specifically advises reducing theophylline dosage when interacting macrolide or fluoroquinolone antibiotics are prescribed for COPD exacerbations; the prescriber determines the change and monitoring, not a universal percentage applied at home.
Starting a strong inhibitor is not the only interaction scenario. Stopping rifampicin, carbamazepine or phenytoin can remove an enzyme-inducing effect and allow a previously tolerated dose to produce higher concentrations over subsequent days. Some of the same smoking and CYP1A2 issues arise in clozapine medication safety, although the relevant tests and treatment thresholds differ.
A complete medication review should include nonprescription products and recently discontinued medicines. Cimetidine bought for indigestion can be relevant even if the regular prescription list has not changed, and a 3-day antibiotic course can overlap with the start of accumulating drug. Ask a pharmacist to check the exact medicine names, including herbal products, and arrange repeat levels according to the expected interaction rather than the package color or drug class alone.
Hoe’t leeftyd, leversykte en hertfalen de klaring beynfloedzje
Older age, significant liver disease and congestive heart failure can reduce theophylline clearance. Product labeling describes reductions of 50% of mear in some patients with liver impairment or heart failure, making an unchanged dose potentially excessive after health status changes.
Theophylline is mainly metabolized by the liver in adults, so a normal creatinine result does not establish normal drug clearance. This differs from medicines whose elimination is predominantly renal; our hantlieding foar de ynterpretaasje fan nierfunksje explains what creatinine does and does not measure. Only a relatively small fraction, roughly 10%, is excreted unchanged in adult urine, although newborn physiology differs substantially.
Normal ALT and AST values cannot rule out reduced theophylline metabolism. Heart failure, hepatic congestion and changes in liver functional reserve can affect clearance without a proportionate rise in routine enzyme tests. In a hypothetical adult with worsening edema, breathlessness and a rise from 9 to 18 mg/L on the same dose, the relevant question is what changed physiologically—not whether the tablet count remained correct.
Adults over 60 years often need more cautious dosing and review, particularly when frailty, hypoxia or multiple interacting medicines coexist. Our guide to medisynynfloeden by âlderen explains why a previously tolerated regimen can become unsuitable. Age is a risk modifier rather than a stand-alone dose formula; children, pregnancy and neonatal use require separate specialist interpretation rather than applying an adult 5–15 mg/L target indiscriminately.
Wat in lege spegel betsjut—en wat kafee feroaret
A low theophylline level does not automatically require a higher dose. In resultaat ûnder 5 mg/L may reflect sampling time, missed doses, faster clearance or an intentionally low target; caffeine can worsen tremor and palpitations without necessarily explaining the measured concentration.
Clinical benefit determines whether a low concentration is a problem. A correctly timed result of 4 mg/L in someone with good control may need a treatment review rather than automatic escalation, whereas the same result with worsening breathlessness requires assessment of the whole respiratory regimen. Check adherence and technique for other prescribed treatments before assuming that raising theophylline will provide the missing benefit.
Coffee, strong tea, energy drinks and cocoa add methylxanthine exposure, which can compound insomnia, tremor or palpitations. Approximately 80–100 mg of caffeine in a typical cup of brewed coffee is a useful reference, but portions and preparations vary widely. Unlike an overdose assessment described in our salicylate level timing guide, a caffeine history does not replace measurement of the prescribed drug.
Missed doses should not be corrected by doubling the next dose unless the prescriber has explicitly instructed it. For a hypothetical twice-daily regimen, taking two 200 mg doses together can create a different peak from taking them 12 hours apart, even when the daily total appears unchanged. Keep caffeine intake reasonably consistent, follow the medicine’s missed-dose instructions and never use extra fluids, food or supplements as a home treatment for suspected toxicity.
Wat bart der nei in hege teofyllinespegel?
A high theophylline level requires assessment of symptoms, exposure pattern and whether the concentration is rising. Results above 20 mg/L warrant prompt clinical advice; markedly elevated levels or significant symptoms need urgent hospital assessment, with treatment guided by more than the number.
Acute overdose and chronic accumulation have different risk patterns. An older adult accumulating drug over several days may develop serious toxicity at a lower concentration than a younger person after a single ingestion, so a universal “danger starts here” cutoff is misleading. A result above 30 mg/L during regular treatment is especially concerning, and a recent extra modified-release dose can make an early measurement underestimate the eventual peak.
Hospital assessment commonly includes serial theophylline levels, an ECG, potassium, magnesium, glucose and acid–base evaluation. Activated charcoal may be used under medical supervision, sometimes in repeated doses, but suitability depends on airway protection and other risks. The general need to interpret ingestion time resembles overdose sampling decisions; however, the acetaminophen nomogram must never be applied to theophylline.
EXTRIP recommends extracorporeal treatment for severe theophylline poisoning, including an acute concentration above 100 mg/L or severe manifestations such as seizures, life-threatening arrhythmias or shock (Ghannoum et al., 2015). The workgroup also suggests treatment in chronic poisoning above 60 mg/L, with additional lower-threshold considerations for vulnerable age groups. These are specialist treatment criteria—not concentrations below which home observation is automatically safe.
Hoe’t jo útslaggen ferlykje en in nuttige werhellingstest planne
Two theophylline results are comparable only when dose, formulation and sampling conditions are sufficiently similar. In feroaring fan 8 to 14 mg/L may represent real accumulation, a later peak sample or both; repeat testing should answer a specific clinical question.
Consider a hypothetical 58-year-old taking 200 mg of modified-release theophylline every 12 hours. A level of 8 mg/L drawn immediately before a dose and a later level of 14 mg/L drawn 5 hours afterward cannot establish worsening clearance by themselves. The practical next step is to confirm the intended sampling window and repeat under the prescriber’s instructions, unless symptoms require immediate assessment instead.
Now consider a different hypothetical person whose comparable levels rise from 10 to 18 mg/L after 7 days without cigarettes. The unchanged formulation and matched dose-to-sample interval make reduced clearance a stronger explanation, especially if nausea has appeared. Our listet de resultaatferoarings dy't de muoite wurdich binne om te dokumintearjen. explains why the timeline of smoking, fever and prescription changes belongs beside the laboratory trend.
Kantesti is an AI-powered blood test analysis tool that can help organize a 10-to-18 mg/L trend alongside the history you provide. Ús AI-ynterpretaasjemetoade explains how supplied context supports interpretation without replacing clinician oversight. Before a repeat test, confirm five details: exact product, dose schedule, last-dose time, sample time and relevant changes; after an intervention, the prescriber chooses when the new level will be informative.
Undersyks publikaasjes en de grinzen fan AI-ynterpretaasje
Theophylline interpretation rests on pharmacology, product-specific monitoring and clinical assessment—not an AI-generated safe cutoff. A total result of 12 mg/L can be useful evidence, but published ranges and automated explanations cannot exclude toxicity in a symptomatic person.
The evidence supports different roles for theophylline at different concentrations, but a biological mechanism is not the same as proven benefit for every treatment strategy. Barnes’s 2013 review discusses proposed effects at lower levels alongside bronchodilation at higher exposure, while NICE’s 2018 COPD guidance emphasizes selective use and monitoring. Neither source establishes a universally safe 5–15 mg/L interval independent of symptoms, formulation and individual risk.
Extracorporeal-treatment thresholds address severe poisoning rather than routine therapeutic monitoring. Ghannoum and colleagues’ EXTRIP review uses criteria such as an acute concentration above 100 mg/L, but its recommendations also respond to severe symptoms and the exposure pattern. Our guide to it kontrolearjen fan medyske útlis troch AI helps readers distinguish a hospital treatment threshold from a personal treatment target.
The two Kantesti publications listed below describe a validation framework and a global analysis report; they are not theophylline-specific trials or independent prescribing guidelines. They should not be cited as proof that an AI system can diagnose toxicity at 17 mg/L or safely change a dose. Our medyske ynhâldsnoarmen require that separation: use educational interpretation to prepare questions, and use the prescribing team or emergency services for clinical decisions.
Faak stelde fragen
Wat is it terapeutyske berik foar teofylline?
Doelwearden foar behanneling mei teofylline falle ornaris binnen 5–15 mg/L, hoewol't guon laboratoaria in therapeutysk berik fan 10–20 mg/L rapportearje. De foarskriuwer kin in legere doelwearde kieze, ôfhinklik fan it foardiel, de bywurkingen, de leeftyd en oare sykten. It tiidstip fan de monstername moat oerienkomme mei it produkt en de bedoelde ynterpretaasje as pyk- of dalwearde. In resultaat binnen it berik fan it laboratoarium garandearret gjin feiligens.
Is in teofyllinespegel fan 20 giftich?
In the teofyllinespiegel fan 20 mg/L leit oan de boppegrins fan in protte tradisjonele laboratoariumberikken, en boppe dy konsintraasje wurdt toksisiteit wierskynliker. Guon minsken krije bywurkingen ûnder 20 mg/L, benammen by chronyske opbou of in ferhege gefoelichheid. In útslach fan 20 mg/L moat dêrom beoardiele wurde yn relaasje ta it doel fan de behanneljend dokter, it tiidstip fan de doasis en de symptomen. Oanhâldend braken, in flugge hertslach of neurologyske symptomen freegje om driuwend medysk advys, yn stee fan gerêststelling op basis fan it berik.
Wannear moat in teofyllinespegel bepaald wurde?
0 De tiid foar it nimmen fan in teofyllinmonster hinget ôf fan 'e formulearring en it doel fan 'e monitoaring. Produkten mei direkte frijlitting berikke faak in pyk sawat 1–2 oeren nei in dosis, wylst by guon protokollen foar modifisearre frijlitting in monster 4–6 oeren nei de dosis nommen wurdt. Oare produkten fereaskje in oare timing, en in dalwearde wurdt fuort foar de folgjende plande dosis bepaald. By fertinking op toksisiteit moat fuortendaliks beoardiele wurde, ynstee fan te wachtsjen op in gewoan monsternamefinster.
Kin ophâlde mei smoken de teofyllinespegels ferheegje?
Ophâlde mei smoken kin de teofylline-nivo's ferheegje, om't tabaksreek enzymen aktivearret dy't belutsen binne by it ôffieren fan it medisyn. Neffens de produktynformaasje nimt de klaring nei 1 wike fan ûnthâlding mei likernôch 40% ôf, hoewol't yndividuele feroaringen ferskille. Nikotinepleisters of -kaugom foarkomme dizze ynteraksje net betrouber, om't nikotine net de wichtichste oarsaak is fan 'e enzymaktivearring. Lit it foarskriuwende team witte wannear't it smoken ophâldt, flink minder wurdt of opnij begjint, sadat se monitoaring en eventuele dose-oanpassing planne kinne.
Kin koarts it teofyllinegehalte ferheegje?
Oanhâldende koarts kin it teofyllinenivo ferheegje troch de klaring fan it medisyn te fertragjen, sels as de dosis net feroaret. Temperatueren om de 39°C hinne dy't op syn minst 24 oeren oanhâlde, binne in erkend warskôgingspatroan yn produktynformaasje, mar ek oare wichtige of langduorjende sykten kinne fan belang wêze. Ynteraksjonearjende antibiotika kinne dit effekt fersterkje by in luchtweginfeksje. Nije braken, triljen of hertkloppingen moatte oanlieding wêze om driuwend medysk advys yn te winnen en in aktueel medisinenivo te beskôgjen.
Wat moat ik dwaan as myn teofyllinespegel heech is?
In teofyllinespegel boppe 20 mg/L freget om prompt klinysk advys, wylst in sterk ferhege resultaat of wichtige symptomen in driuwende sikehûsbeoardieling fereaskje kinne. Sykje fuortendaliks needhelp by in kramp, ynstoarten, slimme betizing of in oanhâldend rappe of ûnregelmjittige hertslach, ûnôfhinklik fan de mjitten konsintraasje. As der in fertocht is op toksisiteit, nim dan gjin oare teofyllinedosis oant jo driuwend advys krigen hawwe. Besykje net braken op te wekken, brûk gjin behanneling mei aktivearre koal thús en berekkenje net sels in dosisfermindering op basis fan it laboratoariumresultaat.
Lit jo bloedtest resultaten útlizze
Laad jo laboratoariumrapport op en de AI fan Kantesti leit elke biomarker binnen sekonden út yn gewoane taal. Brûkt troch mear as 2 miljoen minsken wrâldwiid.
Referinsjes
- Klein, T., Mitchell, S., & Weber, H. (2026). Klinysk Falidaasjekader v2.0 (Medyske Falidaasjeside). Kantesti AI Medysk Undersyk. DOI
- Klein, T., Mitchell, S., & Weber, H. (2026). AI Bloedtest Analyzer: 2.5M Tests Analiseerd | Global Health Report 2026. Kantesti AI Medysk Undersyk. DOI
- Barnes PJ (2013). Theophylline. American Journal of Respiratory and Critical Care Medicine. DOI
- National Institute for Health and Care Excellence (2018). Chronic obstructive pulmonary disease in over 16s: diagnosis and management. NICE Guideline NG115.
- Ghannoum M et al. (2015). Extracorporeal treatment for theophylline poisoning: systematic review and recommendations from the EXTRIP workgroup. Clinical Toxicology. DOI
- 2M+Analysearre tests
- 127+Lannen
- 100+Talen
Oer it medyske team
E-E-A-T fertrouwensignalen
Ûnderfining
Dokter-oandreaune klinyske resinsje fan lab-ynterpretaasje-wurkprosessen.
Ekspertize
Fokus fan laboratoariummedisyne op hoe’t biomarkers har gedrage yn in klinyske kontekst.
Autoriteit
Medysk beoardiele troch Dr. Thomas Klein, mei bydragen fan Dr. Sarah Mitchell en prof. dr. Hans Weber.
Betrouberens
Bewiis-basearre ynterpretaasje mei dúdlike ferfolchpaadkes om alarm te ferminderjen.
Medyske disclaimer
Dit artikel is allinnich foar ûnderwiisdoelen en foarmet gjin medysk advys. Rieplachtsje altyd in kwalifisearre soarchferliener foar besluten oer diagnoaze en behanneling.
Publisearre · Nim kontakt op mei it redaksjeteam
Publisearre troch Kantesti Ltd, registrearre yn Ingelân en Wales, bedriuwsnûmer. 17090423, Londen, Feriene Keninkryk.
